| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/26/2004 | US20040166097 Therapy for bone disease or lung defect |
| 08/26/2004 | US20040166095 Graft versus host disease; administering lymphocytes ,hematopoietic stem cells |
| 08/26/2004 | US20040166092 Use of viral vectors and charged molecules for gene therapy |
| 08/26/2004 | US20040166091 Materials and methods for treating disorders of the ear |
| 08/26/2004 | US20040166090 Antitumor agents; induction apoptosis |
| 08/26/2004 | US20040166061 drug screening for antidiabetic or antiobesity agents by determining whether a test compound activates expression of the human transcription factor gene FKHL14/FOXC2, winged helix protein; using mouse model of obesity to test the potential drug |
| 08/26/2004 | DE10305213A1 Verwendung eines neuen Polymorphismus im hsgk1-Gen zur Diagnose der Hypertonie und Verwendung der sgk-Genfamilie zur Diagnose und Therapie des Long-Q/T-Syndroms Use of a new polymorphism in the gene hsgk1 for diagnosing hypertension and use of the sgk gene family for the diagnosis and therapy of the Long-Q / T syndrome |
| 08/26/2004 | DE10305138A1 Composition, useful for the prophylaxis/treatment of hepatitis C virus infection and/or associated diseases, comprises an agent e.g. selenium, all trans retinoic acid or 9-cis retinoic acid |
| 08/26/2004 | DE10304660A1 Method of screening for pain-regulating compounds, useful for therapy and diagnosis, based on their ability to bind to specific nucleic acid sequences or proteins, identified as being pain regulated |
| 08/26/2004 | DE10303229A1 α-Liponsäure, Ambroxol und/oder Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen α-lipoic acid, ambroxol and / or inhibitors of the angiotensin converting enzyme (ACE) comprehensive drug preparation and their use for the treatment of neurodegenerative diseases |
| 08/26/2004 | CA2640585A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one |
| 08/26/2004 | CA2556351A1 Antimicrobial agents from streptococcus mitis and streptococcus oralis |
| 08/26/2004 | CA2555510A1 Antiplasmin cleaving enzyme |
| 08/26/2004 | CA2520591A1 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | CA2516344A1 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | CA2515708A1 Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies using a formylglycine generating enzyme (fge) |
| 08/26/2004 | CA2515699A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | CA2515677A1 Methods for monitoring drug activities in vivo |
| 08/26/2004 | CA2515608A1 Stem cell factor for preventing chemotherapy-induced depletion of blood cells |
| 08/26/2004 | CA2515607A1 Use of lupinus albus conglutin gamma for the treatment of type ii diabetes |
| 08/26/2004 | CA2515395A1 New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 08/26/2004 | CA2515368A1 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 08/26/2004 | CA2515216A1 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | CA2515022A1 Method for treating elevated intraocular pressure, including glaucoma |
| 08/26/2004 | CA2514969A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 08/26/2004 | CA2514955A1 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | CA2514794A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/26/2004 | CA2514316A1 Compositions and methods for enhancing apoptosis |
| 08/26/2004 | CA2514163A1 Albumin solution and method for the production thereof |
| 08/26/2004 | CA2456873A1 West nile virus proteins and genes coding the foregoing and their use in vaccinal, therapeutic and diagnostic applications |
| 08/25/2004 | EP1449922A2 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 08/25/2004 | EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/25/2004 | EP1449849A2 Protease-resistant thrombomodulin analog |
| 08/25/2004 | EP1449842A1 Process for the preparation of pyrazolopyridine tartrates |
| 08/25/2004 | EP1449542A1 Genetic remedies for neurodegenerative diseases |
| 08/25/2004 | EP1449539A2 Prophylactic or therapeutic use of a Fas antagonist to inhibit Fas-mediated apoptosis |
| 08/25/2004 | EP1449538A1 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1449536A1 Prion proteins (PrP) as therapeutic agents for the treatment of AP-1 associated diseases |
| 08/25/2004 | EP1449535A1 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 08/25/2004 | EP1449528A1 Treatment of respiratory diseases |
| 08/25/2004 | EP1449522A1 A free radical quenching liposomal composition |
| 08/25/2004 | EP1448986A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 08/25/2004 | EP1448771A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448770A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448765A2 Matrix for the production of tissue engineered ligaments, tendons and other tissue |
| 08/25/2004 | EP1448762A2 Antisense modulation of toll-like receptor 4 expression field of the invention |
| 08/25/2004 | EP1448603A2 Fusion proteins containing tlp peptides |
| 08/25/2004 | EP1448602A2 Modified anti-tnf alpha antibody |
| 08/25/2004 | EP1448600A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39 |
| 08/25/2004 | EP1448599A2 Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| 08/25/2004 | EP1448595A1 Antimicrobial polypeptides from pseudoplectania nigrella |
| 08/25/2004 | EP1448594A2 A food grade lantibiotic from streptococcus macedonicus and uses thereof |
| 08/25/2004 | EP1448593A2 Alpha-fetoprotein peptides and uses thereof |
| 08/25/2004 | EP1448590A2 Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways |
| 08/25/2004 | EP1448589A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 08/25/2004 | EP1448588A2 Psma antibodies and protein multimers |
| 08/25/2004 | EP1448587A2 Noonan syndrome gene |
| 08/25/2004 | EP1448586A2 Therapeutic methods for nucleic acid delivery vehicles |
| 08/25/2004 | EP1448585A2 Antisense modulation of inhibitor-kappa b kinase-gamma expression |
| 08/25/2004 | EP1448583A2 A novel g protein-coupled receptor, gave8 |
| 08/25/2004 | EP1448582A2 Telomerase interference |
| 08/25/2004 | EP1448580A2 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/25/2004 | EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 08/25/2004 | EP1448456A1 Transdermal/transmucosal patch packaging |
| 08/25/2004 | EP1448281A2 Therapeutic coating for an intravascular implant |
| 08/25/2004 | EP1448246A1 Device having osteoinductive and osteoconductive properties |
| 08/25/2004 | EP1448237A1 Selective treatment of il-13 expressing tumors |
| 08/25/2004 | EP1448233A2 Endothelin antagonists ina method and composition for potentiating an opiate analgesic |
| 08/25/2004 | EP1448231A1 Topical delivery of codrugs |
| 08/25/2004 | EP1448230A2 Adjuvanted antigenic meningococcal compositions |
| 08/25/2004 | EP1448228A2 Management of postoperative pain |
| 08/25/2004 | EP1448227A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 08/25/2004 | EP1448226A1 Agonists and antagonists of prolixin for the treatment of metabolic disorders |
| 08/25/2004 | EP1448225A1 Agonists and antagonists of ryzn for the treatment of metabolic disorders |
| 08/25/2004 | EP1448224A2 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 08/25/2004 | EP1448223A2 Thymosin augmentation of genetic immunization |
| 08/25/2004 | EP1448222A1 Biphasic mixtures of glp-1 and insulin |
| 08/25/2004 | EP1448221A1 Injection solution comprising an lhrh antagonist |
| 08/25/2004 | EP1448220A2 Antiphlogistic agent and the use thereof |
| 08/25/2004 | EP1448219A1 Antiglaucomatous agent and use thereof |
| 08/25/2004 | EP1448218A2 Beta-secretase inhibitors and methods of use |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448211A1 A composition for lowering the concentration of intestinal pathogenic peptides |
| 08/25/2004 | EP1448210A2 REGULATION OF cGMP-SPECIFIC PHOSPHODIESTERASE 9A |
| 08/25/2004 | EP1448191A1 Ilk inhibitors for the treatment of renal disease |
| 08/25/2004 | EP1448179A1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/25/2004 | EP1448167A1 New use of ethoxylated phytosterols and phytostanols |
| 08/25/2004 | EP1448152A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 08/25/2004 | EP1448151A1 Dosage form, device and methods of treatment |
| 08/25/2004 | EP1448127A1 Compositions for the treatment of infectious diseases |
| 08/25/2004 | EP1448089A2 Devices and methods for the restoration of a spinal disc |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1448053A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 08/25/2004 | EP1385942A4 Regulation of target protein activity through modifier proteins |
| 08/25/2004 | EP1372641A4 Enteral formulation |
| 08/25/2004 | EP1353939B1 Tetrapeptide regulating prostate functions and its compositions and uses |
| 08/25/2004 | EP1311277A4 Methods of modulating fibrosis |
| 08/25/2004 | EP1228235B1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |